Archive


Category: Dominic Tyer

  • Pfizer: Pharma needs a business strategy for a digital world

    The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has set in train an age of digital transformation. In my last article, I outlined the inflection point facing the pharmaceutical industry in digital health and the digital transformation of its clinical and commercial operations. This time I’m going to focus […]

  • BMS’ Catherine Owen: Hybrid communication is here to stay

    The company’s senior vice president for major markets (Europe, Canada and Japan) talks about the continued evolution of pharma’s approach to communications and commercialisation. The core of Bristol Myers Squibb’s commercial business outside its home base of the US covers most of the large countries in Europe, as well as Canada and Japan. These 19 […]